Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh Mullangi

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 31, 2019
Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroximeRavi Kumar Jairam, Sadanand R Mallurwar, Bhavesh B Gabani, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2017
LC-MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic studySreekanth Dittakavi, Pavan Kumar V S P Nagasuri, Suresh P Sulochana, et al.
Biomedical Chromatography : BMC|December 8, 2016
Validation of an LC-MS/MS method for simultaneous detection of four HDAC inhibitors - belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic studyKalpesh Kumar Giri, P S Suresh, Syed Mohd Saim, et al.
Journal of Clinical Pharmacology|June 5, 2002
Lack of effect of sucralfate on the absorption and pharmacokinetics of rosiglitazoneMamidi N V S Rao, Ramesh Mullangi, Kasiram Katneni, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 22, 2019
Stereoselective pharmacokinetics and tissue distribution of levodropropizine after administration of pure levodropropizine and the <i>rac</i>-dropropizine to Sprague-Dawley ratsBhavesh Babulal Gabani, Umesh Todmal, Neeraj Kumar Saini, et al.
Biomedical Chromatography : BMC|September 21, 2010
Development and validation of a highly sensitive LC-MS/MS method for simultaneous quantitation of nortriptyline and 10-hydroxynortriptyline in human plasma: application to a human pharmacokinetic studyKishore Kumar Hotha, L K Ravindranath, K N Jaya Veera, et al.
Bioorganic & Medicinal Chemistry|September 5, 2006
Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administrationSunil Kumar Singh, Saibaba Vobbalareddy, Srinivasa Rao Kalleda, et al.
Journal of Clinical Pharmacology|March 22, 2005
Safety, tolerability, and pharmacokinetics of a capsule formulation of DRF-1042, a novel camptothecin analog, in refractory cancer patients in a bridging phase I studyArani Chatterjee, Raghunadharao Digumarti, Kasiram Katneni, et al.
Biomedical Chromatography : BMC|August 8, 2008
Assessing the issue of instability due to Michael adduct formation in novel chemical entities possessing a carbon-carbon double bond during early drug development--applicability of common laboratory analytical protocolsAkshanth Reddy Polepally, Venkata V Pavan Kumar, Ravikanth Bhamidipati, et al.
Journal of Medicinal Chemistry|September 5, 2003
Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulationManojit Pal, Manjula Madan, Srinivas Padakanti, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 31, 2019
Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroximeRavi Kumar Jairam, Sadanand R Mallurwar, Bhavesh B Gabani, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2017
LC-MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic studySreekanth Dittakavi, Pavan Kumar V S P Nagasuri, Suresh P Sulochana, et al.
Biomedical Chromatography : BMC|December 8, 2016
Validation of an LC-MS/MS method for simultaneous detection of four HDAC inhibitors - belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic studyKalpesh Kumar Giri, P S Suresh, Syed Mohd Saim, et al.
Journal of Clinical Pharmacology|June 5, 2002
Lack of effect of sucralfate on the absorption and pharmacokinetics of rosiglitazoneMamidi N V S Rao, Ramesh Mullangi, Kasiram Katneni, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 22, 2019
Stereoselective pharmacokinetics and tissue distribution of levodropropizine after administration of pure levodropropizine and the <i>rac</i>-dropropizine to Sprague-Dawley ratsBhavesh Babulal Gabani, Umesh Todmal, Neeraj Kumar Saini, et al.
Biomedical Chromatography : BMC|September 21, 2010
Development and validation of a highly sensitive LC-MS/MS method for simultaneous quantitation of nortriptyline and 10-hydroxynortriptyline in human plasma: application to a human pharmacokinetic studyKishore Kumar Hotha, L K Ravindranath, K N Jaya Veera, et al.
Bioorganic & Medicinal Chemistry|September 5, 2006
Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administrationSunil Kumar Singh, Saibaba Vobbalareddy, Srinivasa Rao Kalleda, et al.
Journal of Clinical Pharmacology|March 22, 2005
Safety, tolerability, and pharmacokinetics of a capsule formulation of DRF-1042, a novel camptothecin analog, in refractory cancer patients in a bridging phase I studyArani Chatterjee, Raghunadharao Digumarti, Kasiram Katneni, et al.
Biomedical Chromatography : BMC|August 8, 2008
Assessing the issue of instability due to Michael adduct formation in novel chemical entities possessing a carbon-carbon double bond during early drug development--applicability of common laboratory analytical protocolsAkshanth Reddy Polepally, Venkata V Pavan Kumar, Ravikanth Bhamidipati, et al.
Journal of Medicinal Chemistry|September 5, 2003
Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulationManojit Pal, Manjula Madan, Srinivas Padakanti, et al.
Pageof 19